Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Allison O. Taylor"'
Autor:
Kaitlyn C. Dykes, Jiling Chou, Allison O. Taylor, Albert C. Shu, Sarah E. Mudra, Xiaoyang Ma, Jaeil Ahn, Catherine E. Lai
Publikováno v:
Cancer Reports, Vol 7, Iss 8, Pp n/a-n/a (2024)
ABSTRACT Bakground It is important to understand the outcomes of adult acute lymphoblastic leukemia (ALL) patients at different facilities as treatment paradigms change. Aims Our primary objective was to determine adult ALL overall survival (OS) by f
Externí odkaz:
https://doaj.org/article/aa68d8500ee5455e8082e852494f7f5e
Autor:
Andrea Schmidts, Maria Ormhøj, Bryan D. Choi, Allison O. Taylor, Amanda A. Bouffard, Irene Scarfò, Rebecca C. Larson, Matthew J. Frigault, Kathleen Gallagher, Ana P. Castano, Lauren S. Riley, Maria L. Cabral, Angela C. Boroughs, Rubí M.-H. Velasco Cárdenas, Wolfgang Schamel, Jing Zhou, Sean Mackay, Yu-Tzu Tai, Kenneth C. Anderson, Marcela V. Maus
Publikováno v:
Blood Advances, Vol 3, Iss 21, Pp 3248-3260 (2019)
Abstract: Chimeric antigen receptor (CAR) T cells (CARTs) have shown tremendous potential for the treatment of certain B-cell malignancies, including patients with relapsed/refractory multiple myeloma (MM). Targeting the B-cell maturation antigen (BC
Externí odkaz:
https://doaj.org/article/744190eefb7f4eac95dde4520a55224b
Autor:
Kimberley Doucette, Allison O. Taylor, Bryan Chan, Xiaoyang Ma, Jaeil Ahn, David H. Vesole, Catherine Lai
Publikováno v:
Annals of Hematology. 102:1443-1458
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e80a5722728628449b5ad7060fed9786
https://doi.org/10.1007/s00277-023-05194-6
https://doi.org/10.1007/s00277-023-05194-6
Publikováno v:
Annals of Cancer Epidemiology. 7:2-2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62c6f6f33a9bbd03635d2c6956eb6d69
https://doi.org/10.21037/ace-22-12
https://doi.org/10.21037/ace-22-12
Publikováno v:
Journal of Clinical Oncology. 39:12087-12087
12087 Background: AML is an aggressive disease with high mortality and significant impact on quality of life. Palliative care (PC) services have become integral in managing patient’s symptoms during treatment as well as at the end of life. We hypot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd6f22d50f011d9ba9bad7337235c13e
https://doi.org/10.1200/jco.2021.39.15_suppl.12087
https://doi.org/10.1200/jco.2021.39.15_suppl.12087